Bianca Plouffe Stands out at Concours Étudiants-Chercheurs Étoiles

Published on October 27, 2016

This October, a new student ranked in the List of Étudiants-Chercheurs Étoiles: Bianca Plouffe, a postdoctoral researcher in biochemistry in the laboratory of Michel Bouvier from the Institute for Research in Immunology and Cancer (IRIC) at Université de Montréal (UdeM), is a prize winner in the “Health” section of Fonds de Recherche du Québec. Bianca Plouffe was awarded $1,000 for her study published in the prestigious scientific journal Cell: “GPCR-G Protein-β-Arrestin Super-Complex Mediates Sustained G Protein Signaling 

About this discovery that could have considerable impact on the development of new drugs, you can read this following article: “Researchers discovered a new protein complex playing a role in G protein-coupled receptors (GPCRs) ”.

On the same subject:

Referenced study

Alex R. B. Thomsen1, Bianca Plouffe1, Thomas J. Cahill III1, Arun K. Shukla, Jeffrey T. Tarrasch, Franziska Heydenreich, Annie M. Dosey, Alem W. Kahsai, Ryan T. Strachan, Biswaranjan Pani, Jacob P. Mahoney, Liyin Huang, Billy Breton, Roger K. Sunahara, Georgios Skiniotis, Michel Bouvier2, Robert J. Lefkowitz2
GPCR-G Protein-β-Arrestin Super-Complex Mediates Sustained G Protein Signaling.
1Co-first authors

2Co-corresponding senior authors

View abstract and full article
About the Étudiants-chercheurs étoiles Award from the Fonds de recherche du Québec

The competition aims to recognize the exceptional research contributions of college and university students, postdoctoral fellows and members of professional bodies who are enrolled in advanced research training programs in the areas covered by the three Fonds de recherche du Québec. For more information:

About the Institute for Research in Immunology and Cancer

An ultra-modern research hub and training centre located in the heart of the Université de Montreal, the Institute for Research in Immunology and Cancer (IRIC) was created in 2003 to shed light on the mechanisms of cancer and discover new, more effective therapies to counter this disease. IRIC operates according to a model that is unique in Canada. Its innovative approach to research has already led to discoveries that will, over the coming years, have a significant impact on the fight against cancer. For further information


Olivier Dilain
Communication and media relations advisor
Institute for Research in Immunology and Cancer│IRIC
Université de Montréal│514-343-7283